Caption Management, LLC Verve Therapeutics, Inc. Put Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	SELL	$13.34 - $19.9 $100,050 - $149,250	-7,500 Reduced 25.0%	22,500 $421,000
Q1 2023 May 15, 2023	BUY	$14.3 - $24.01 $429,000 - $720,300	30,000 New	30,000 $432,000
Q3 2022 Nov 14, 2022	BUY	$15.63 - $41.49 $246,954 - $655,542	15,800 New	15,800 $542,000
Q2 2022 Aug 15, 2022	SELL	$11.14 - $23.17 $15,596 - $32,438	-1,400 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$20.92 - $39.36 $29,288 - $55,104	1,400 New	1,400 $32,000

186

73.3M

85K

215K

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $273M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.